Authors: NEHME A ALBIN N CALIARO MJ GUICHARD S JOZAN S JULIA AM BUGAT R CANAL P

Citation: A. Nehme et al., MECHANISM OF INTERACTION BETWEEN CISPLATIN AND HUMAN RECOMBINANT INTERFERON-GAMMA IN HUMAN OVARIAN-CANCER CELL-LINES, International journal of cancer, 61(5), 1995, pp. 643-648

Authors: NEHME A JULIA AM JOZAN S CHEVREAU C BUGAT R CANAL P

Citation: A. Nehme et al., MODULATION OF CISPLATIN CYTOTOXICITY BY HUMAN RECOMBINANT INTERFERON-GAMMA IN HUMAN OVARIAN-CANCER CELL-LINES, European journal of cancer, 30A(4), 1994, pp. 520-525

Authors: NEHME A ALBIN N JULIA AM JOZAN S BUGAT R CANAL P

Citation: A. Nehme et al., MECHANISMS OF INTERACTION BETWEEN CISPLAT IN AND HUMAN RECOMBINANT INTERFERON-GAMMA (INF-GAMMA) IN HUMAN OVARIAN-CANCER CELL-LINES, Bulletin du cancer, 81(11), 1994, pp. 934-934

Authors: JULIA AM ROCHE H BERLION M LUCAS C MILANO G ROBERT J BIZZARI JP CANAL P

Citation: Am. Julia et al., MULTIDRUG-RESISTANCE CIRCUMVENTION HY A NEW TRIAZINOAMINOPIPERIDINE DERIVATIVE S9788 IN-VITRO - DEFINITION OF THE OPTIMAL SCHEDULE AND COMPARISON WITH VERAPAMIL, British Journal of Cancer, 69(5), 1994, pp. 868-874

Authors: ROCHE H JULIA AM JOZAN S MULLER C DASTUGUE N ARQUIER MA MARQUES B LAURENT G CANAL P

Citation: H. Roche et al., CHARACTERIZATION AND CHEMOSENSITIVITY OF A HUMAN EPITHELIOID SARCOMA CELL-LINE (SARCCR-2), International journal of cancer, 54(4), 1993, pp. 663-668